These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 28610674)

  • 1. Elevated serum D-dimer level is associated with an increased risk of acute exacerbation in interstitial lung disease.
    Ishikawa G; Acquah SO; Salvatore M; Padilla ML
    Respir Med; 2017 Jul; 128():78-84. PubMed ID: 28610674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of interleukin-6 as a prognostic biomarker for predicting acute exacerbation in interstitial lung diseases.
    Lee JH; Jang JH; Park JH; Jang HJ; Park CS; Lee S; Kim SH; Kim JY; Kim HK
    PLoS One; 2021; 16(7):e0255365. PubMed ID: 34314462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum oncomarkers for patients hospitalized with acute exacerbation of interstitial lung disease.
    Ba C; Jiang C; Wang H; Shi X; Jin J; Fang Q
    Ther Adv Respir Dis; 2024; 18():17534666241250332. PubMed ID: 38757948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study.
    Cao M; Sheng J; Qiu X; Wang D; Wang D; Wang Y; Xiao Y; Cai H
    BMC Pulm Med; 2019 Nov; 19(1):215. PubMed ID: 31727051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease.
    Kono M; Miyashita K; Hirama R; Oshima Y; Takeda K; Mochizuka Y; Tsutsumi A; Miwa H; Miki Y; Hashimoto D; Suda T; Nakamura H
    Respir Med; 2021 Sep; 186():106534. PubMed ID: 34260978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients With Fibrotic Interstitial Lung Disease Hospitalized for Acute Respiratory Worsening: A Large Cohort Analysis.
    Moua T; Westerly BD; Dulohery MM; Daniels CE; Ryu JH; Lim KG
    Chest; 2016 May; 149(5):1205-14. PubMed ID: 26836940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features and outcome of acute exacerbation in connective tissue disease-associated interstitial lung disease: A single-center study from India.
    Singh P; Thakur B; Mohapatra AK; Padhan P
    Int J Rheum Dis; 2019 Sep; 22(9):1741-1745. PubMed ID: 31328423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between acute exacerbation and progressive pulmonary fibrosis in interstitial lung disease: a retrospective cohort study.
    Zhai L; Wang Z; Yu W
    Ther Adv Respir Dis; 2024; 18():17534666241276800. PubMed ID: 39235441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute exacerbations of fibrotic interstitial lung diseases.
    Suzuki A; Kondoh Y; Brown KK; Johkoh T; Kataoka K; Fukuoka J; Kimura T; Matsuda T; Yokoyama T; Fukihara J; Ando M; Tanaka T; Hashimoto N; Sakamoto K; Hasegawa Y
    Respirology; 2020 May; 25(5):525-534. PubMed ID: 31426125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical manifestations and prognostic factors analysis of patients hospitalised with acute exacerbation of idiopathic pulmonary fibrosis and other interstitial lung diseases.
    Ba C; Wang H; Jiang C; Shi X; Jin J; Fang Q
    BMJ Open Respir Res; 2024 Feb; 11(1):. PubMed ID: 38413119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute exacerbations of fibrotic interstitial lung disease.
    Churg A; Wright JL; Tazelaar HD
    Histopathology; 2011 Mar; 58(4):525-30. PubMed ID: 20854464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalization Rates in Interstitial Lung Disease: An Analysis of the Pulmonary Fibrosis Foundation Registry.
    King CS; Ignacio RV; Khangoora V; Nyquist A; Singhal A; Thomas C; Cantres OF; Aryal S; Shlobin OA; Flaherty K; Lasky J; Nathan SD
    Am J Respir Crit Care Med; 2024 Sep; 210(6):801-813. PubMed ID: 38236191
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical features and outcome of acute exacerbation of interstitial pneumonia: collagen vascular diseases-related versus idiopathic.
    Tachikawa R; Tomii K; Ueda H; Nagata K; Nanjo S; Sakurai A; Otsuka K; Kaji R; Hayashi M; Katakami N; Imai Y
    Respiration; 2012; 83(1):20-7. PubMed ID: 21912082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic evaluation by oxygenation with positive end-expiratory pressure in acute exacerbation of idiopathic pulmonary fibrosis: A retrospective cohort study.
    Suzuki A; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Matsuda T; Yokoyama T; Sakamoto K; Hasegawa Y
    Clin Respir J; 2018 Mar; 12(3):895-903. PubMed ID: 28026113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer.
    Ueno F; Kitaguchi Y; Shiina T; Asaka S; Yasuo M; Wada Y; Kinjo T; Yoshizawa A; Hanaoka M
    Respiration; 2020; 99(1):9-18. PubMed ID: 31554007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema.
    Minegishi Y; Kokuho N; Miura Y; Matsumoto M; Miyanaga A; Noro R; Saito Y; Seike M; Kubota K; Azuma A; Kida K; Gemma A
    Lung Cancer; 2014 Aug; 85(2):258-63. PubMed ID: 24894326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low forced vital capacity predicts cytotoxic chemotherapy-associated acute exacerbation of interstitial lung disease in patients with lung cancer.
    Enomoto Y; Inui N; Kato T; Baba T; Karayama M; Nakamura Y; Ogura T; Suda T
    Lung Cancer; 2016 Jun; 96():63-7. PubMed ID: 27133752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis.
    Enomoto N; Naoi H; Aono Y; Katsumata M; Horiike Y; Yasui H; Karayama M; Hozumi H; Suzuki Y; Furuhashi K; Fujisawa T; Inui N; Nakamura Y; Suda T
    Ther Adv Respir Dis; 2020; 14():1753466620935774. PubMed ID: 32600180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.